Pharma & Healthcare
Global Heart Failure Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 28, 25
- ID: 344564
- Pages: 150
- Figures: 144
- Views: 7
In 2024, the global market size of Heart Failure Drugs was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Heart failure occurs when your heart muscle doesn"t pump blood as well as it should.
The market is concentrated as Novartis, Pfizer, AstraZeneca , Hikma, Teva etc. Turkey is the largest consumption place in the Turkey and Middle East & Africa market, with a consumption market share nearly 21%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Heart Failure Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heart Failure Drugs.
The Heart Failure Drugs market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Heart Failure Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heart Failure Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Novartis
Pfizer
AstraZeneca
Hikma
Teva
Cipla
Merck & Co.
Amgen
Roche
Sun Pharma
Mylan
Segment by Type
ACEI
Angiotensin II Receptor Blockers
ARNIs
Beta Blockers
Aldosterone Antagonists
Diuretics
Segment by Application
Reduced Ejection Fraction
Preserved Ejection Fraction
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Heart Failure Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Heart Failure Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Heart Failure Drugs sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Heart failure occurs when your heart muscle doesn"t pump blood as well as it should.
The market is concentrated as Novartis, Pfizer, AstraZeneca , Hikma, Teva etc. Turkey is the largest consumption place in the Turkey and Middle East & Africa market, with a consumption market share nearly 21%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Heart Failure Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heart Failure Drugs.
The Heart Failure Drugs market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Heart Failure Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heart Failure Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Novartis
Pfizer
AstraZeneca
Hikma
Teva
Cipla
Merck & Co.
Amgen
Roche
Sun Pharma
Mylan
Segment by Type
ACEI
Angiotensin II Receptor Blockers
ARNIs
Beta Blockers
Aldosterone Antagonists
Diuretics
Segment by Application
Reduced Ejection Fraction
Preserved Ejection Fraction
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Heart Failure Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Heart Failure Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Heart Failure Drugs sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Heart Failure Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Heart Failure Drugs Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 ACEI
1.2.3 Angiotensin II Receptor Blockers
1.2.4 ARNIs
1.2.5 Beta Blockers
1.2.6 Aldosterone Antagonists
1.2.7 Diuretics
1.3 Market by Application
1.3.1 Global Heart Failure Drugs Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Reduced Ejection Fraction
1.3.3 Preserved Ejection Fraction
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Heart Failure Drugs Market Size Estimates and Forecasts
2.1.1 Global Heart Failure Drugs Revenue 2020-2031
2.1.2 Global Heart Failure Drugs Sales 2020-2031
2.2 Heart Failure Drugs Market Size by Region: 2024 Versus 2031
2.3 Heart Failure Drugs Sales by Region (2020-2031)
2.3.1 Global Heart Failure Drugs Sales by Region: 2020-2025
2.3.2 Global Heart Failure Drugs Sales Forecast by Region (2026-2031)
2.3.3 Global Heart Failure Drugs Sales Market Share by Region (2020-2031)
2.4 Heart Failure Drugs Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Heart Failure Drugs Revenue by Region: 2020-2025
2.4.2 Global Heart Failure Drugs Revenue Forecast by Region (2026-2031)
2.4.3 Global Heart Failure Drugs Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Heart Failure Drugs Sales by Type (2020-2031)
3.1.1.1 Global Heart Failure Drugs Sales Volume by Type (2020-2031)
3.1.1.2 Global Heart Failure Drugs Sales Market Share by Type (2020-2031)
3.1.2 Global Heart Failure Drugs Revenue by Type (2020-2031)
3.1.2.1 Global Heart Failure Drugs Revenue by Type (2020-2031)
3.1.2.2 Global Heart Failure Drugs Revenue Market Share by Type (2020-2031)
3.1.3 Heart Failure Drugs Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Heart Failure Drugs Sales by Application (2020-2031)
3.2.1.1 Global Heart Failure Drugs Sales Volume by Application (2020-2031)
3.2.1.2 Global Heart Failure Drugs Sales Market Share by Application (2020-2031)
3.2.2 Global Heart Failure Drugs Revenue by Application (2020-2031)
3.2.2.1 Global Heart Failure Drugs Revenue by Application (2020-2031)
3.2.2.2 Global Heart Failure Drugs Revenue Market Share by Application (2020-2031)
3.2.3 Heart Failure Drugs Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 ACEI of Heart Failure Drugs Revenue Market Share by Application
3.3.2 Angiotensin II Receptor Blockers of Heart Failure Drugs Revenue Market Share by Application
3.3.3 ARNIs of Heart Failure Drugs Revenue Market Share by Application
3.3.4 Beta Blockers of Heart Failure Drugs Revenue Market Share by Application
3.3.5 Aldosterone Antagonists of Heart Failure Drugs Revenue Market Share by Application
3.3.6 Diuretics of Heart Failure Drugs Revenue Market Share by Application
4 Global Heart Failure Drugs by Manufacturers
4.1 Global Top Heart Failure Drugs Manufacturers by Sales (2020-2025)
4.1.1 Global Heart Failure Drugs Sales by Manufacturer (2020-2025)
4.1.2 Global Heart Failure Drugs Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Heart Failure Drugs Manufacturers by Revenue (2020-2025)
4.2.1 Global Heart Failure Drugs Revenue by Manufacturer (2020-2025)
4.2.2 Global Heart Failure Drugs Revenue Share by Manufacturer (2020-2025)
4.3 Global Heart Failure Drugs Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Heart Failure Drugs Manufacturers Covered: Ranking by Revenue
4.4.2 Global Heart Failure Drugs Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Heart Failure Drugs Manufacturing Base Distribution, Product Type
4.5.1 Heart Failure Drugs Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Heart Failure Drugs Market
4.5.3 Manufacturers Heart Failure Drugs Product Type and Application
4.5.4 ACEI Market Sales of Heart Failure Drugs by Manufacturer
4.5.5 Angiotensin II Receptor Blockers Market Sales of Heart Failure Drugs by Manufacturer
4.5.6 ARNIs Market Sales of Heart Failure Drugs by Manufacturer
4.5.7 Beta Blockers Market Sales of Heart Failure Drugs by Manufacturer
4.5.8 Aldosterone Antagonists Market Sales of Heart Failure Drugs by Manufacturer
4.5.9 Diuretics Market Sales of Heart Failure Drugs by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Novartis
5.1.1 Novartis Company Information
5.1.2 Novartis Description, Business Overview
5.1.3 Novartis Heart Failure Drugs Products Offered
5.1.4 Novartis Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Novartis Heart Failure Drugs Sales by Product in 2024
5.1.6 Novartis Heart Failure Drugs Sales by Application in 2024
5.1.7 Novartis Heart Failure Drugs Sales by Geographic Area in 2024
5.1.8 Novartis Recent Developments
5.2 Pfizer
5.2.1 Pfizer Company Information
5.2.2 Pfizer Description, Business Overview
5.2.3 Pfizer Heart Failure Drugs Products Offered
5.2.4 Pfizer Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Pfizer Heart Failure Drugs Sales by Product in 2024
5.2.6 Pfizer Heart Failure Drugs Sales by Application in 2024
5.2.7 Pfizer Heart Failure Drugs Sales by Geographic Area in 2024
5.2.8 Pfizer Recent Developments
5.3 AstraZeneca
5.3.1 AstraZeneca Company Information
5.3.2 AstraZeneca Description, Business Overview
5.3.3 AstraZeneca Heart Failure Drugs Products Offered
5.3.4 AstraZeneca Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.3.5 AstraZeneca Heart Failure Drugs Sales by Product in 2024
5.3.6 AstraZeneca Heart Failure Drugs Sales by Application in 2024
5.3.7 AstraZeneca Heart Failure Drugs Sales by Geographic Area in 2024
5.3.8 AstraZeneca Recent Developments
5.4 Hikma
5.4.1 Hikma Company Information
5.4.2 Hikma Description, Business Overview
5.4.3 Hikma Heart Failure Drugs Products Offered
5.4.4 Hikma Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Hikma Heart Failure Drugs Sales by Product in 2024
5.4.6 Hikma Heart Failure Drugs Sales by Application in 2024
5.4.7 Hikma Heart Failure Drugs Sales by Geographic Area in 2024
5.4.8 Hikma Recent Developments
5.5 Teva
5.5.1 Teva Company Information
5.5.2 Teva Description, Business Overview
5.5.3 Teva Heart Failure Drugs Products Offered
5.5.4 Teva Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Teva Heart Failure Drugs Sales by Product in 2024
5.5.6 Teva Heart Failure Drugs Sales by Application in 2024
5.5.7 Teva Heart Failure Drugs Sales by Geographic Area in 2024
5.5.8 Teva Recent Developments
5.6 Cipla
5.6.1 Cipla Company Information
5.6.2 Cipla Description, Business Overview
5.6.3 Cipla Heart Failure Drugs Products Offered
5.6.4 Cipla Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Cipla Heart Failure Drugs Sales by Product in 2024
5.6.6 Cipla Heart Failure Drugs Sales by Application in 2024
5.6.7 Cipla Heart Failure Drugs Sales by Geographic Area in 2024
5.6.8 Cipla Recent Developments
5.7 Merck & Co.
5.7.1 Merck & Co. Company Information
5.7.2 Merck & Co. Description, Business Overview
5.7.3 Merck & Co. Heart Failure Drugs Products Offered
5.7.4 Merck & Co. Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Merck & Co. Heart Failure Drugs Sales by Product in 2024
5.7.6 Merck & Co. Heart Failure Drugs Sales by Application in 2024
5.7.7 Merck & Co. Heart Failure Drugs Sales by Geographic Area in 2024
5.7.8 Merck & Co. Recent Developments
5.8 Amgen
5.8.1 Amgen Company Information
5.8.2 Amgen Description, Business Overview
5.8.3 Amgen Heart Failure Drugs Products Offered
5.8.4 Amgen Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Amgen Heart Failure Drugs Sales by Product in 2024
5.8.6 Amgen Heart Failure Drugs Sales by Application in 2024
5.8.7 Amgen Heart Failure Drugs Sales by Geographic Area in 2024
5.8.8 Amgen Recent Developments
5.9 Roche
5.9.1 Roche Company Information
5.9.2 Roche Description, Business Overview
5.9.3 Roche Heart Failure Drugs Products Offered
5.9.4 Roche Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Roche Heart Failure Drugs Sales by Product in 2024
5.9.6 Roche Heart Failure Drugs Sales by Application in 2024
5.9.7 Roche Heart Failure Drugs Sales by Geographic Area in 2024
5.9.8 Roche Recent Developments
5.10 Sun Pharma
5.10.1 Sun Pharma Company Information
5.10.2 Sun Pharma Description, Business Overview
5.10.3 Sun Pharma Heart Failure Drugs Products Offered
5.10.4 Sun Pharma Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Sun Pharma Heart Failure Drugs Sales by Product in 2024
5.10.6 Sun Pharma Heart Failure Drugs Sales by Application in 2024
5.10.7 Sun Pharma Heart Failure Drugs Sales by Geographic Area in 2024
5.10.8 Sun Pharma Recent Developments
5.11 Mylan
5.11.1 Mylan Company Information
5.11.2 Mylan Description, Business Overview
5.11.3 Mylan Heart Failure Drugs Products Offered
5.11.4 Mylan Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Mylan Heart Failure Drugs Sales by Product in 2024
5.11.6 Mylan Heart Failure Drugs Sales by Application in 2024
5.11.7 Mylan Heart Failure Drugs Sales by Geographic Area in 2024
5.11.8 Mylan Recent Developments
6 North America
6.1 North America Heart Failure Drugs Market Size YoY Growth 2020-2031
6.2 North America Heart Failure Drugs Market Facts & Figures by Country
6.2.1 North America Heart Failure Drugs Sales by Country (2020-2031)
6.2.2 North America Heart Failure Drugs Revenue by Country (2020-2031)
6.3 North America Heart Failure Drugs Sales by Type (2020-2025)
6.4 North America Heart Failure Drugs Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Heart Failure Drugs Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Heart Failure Drugs Market Facts & Figures by Region
7.2.1 Asia-Pacific Heart Failure Drugs Sales by Region (2020-2031)
7.2.2 Asia-Pacific Heart Failure Drugs Revenue by Region (2020-2031)
7.3 Asia-Pacific Heart Failure Drugs Sales by Type (2020-2025)
7.4 Asia-Pacific Heart Failure Drugs Sales by Application (2020-2025)
8 Europe
8.1 Europe Heart Failure Drugs Market Size YoY Growth 2020-2031
8.2 Europe Heart Failure Drugs Market Facts & Figures by Country
8.2.1 Europe Heart Failure Drugs Sales by Country (2020-2031)
8.2.2 Europe Heart Failure Drugs Revenue by Country (2020-2031)
8.3 Europe Heart Failure Drugs Sales by Type (2020-2025)
8.4 Europe Heart Failure Drugs Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Heart Failure Drugs Market Size YoY Growth 2020-2031
9.2 Latin America Heart Failure Drugs Market Facts & Figures by Country
9.2.1 Latin America Heart Failure Drugs Sales by Country (2020-2031)
9.2.2 Latin America Heart Failure Drugs Revenue by Country (2020-2031)
9.3 Latin America Heart Failure Drugs Sales by Type (2020-2025)
9.4 Latin America Heart Failure Drugs Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Heart Failure Drugs Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Heart Failure Drugs Market Facts & Figures by Country
10.2.1 Middle East and Africa Heart Failure Drugs Sales by Country (2020-2031)
10.2.2 Middle East and Africa Heart Failure Drugs Revenue by Country (2020-2031)
10.3 Middle East and Africa Heart Failure Drugs Sales by Type (2020-2025)
10.4 Middle East and Africa Heart Failure Drugs Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Heart Failure Drugs Supply Chain Analysis
11.2 Heart Failure Drugs Key Raw Materials and Upstream Suppliers
11.3 Heart Failure Drugs Clients Analysis
11.4 Heart Failure Drugs Sales Channel and Sales Model Analysis
11.4.1 Heart Failure Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Heart Failure Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Heart Failure Drugs Distributors
12 Heart Failure Drugs Market Dynamics
12.1 Heart Failure Drugs Industry Trends
12.2 Heart Failure Drugs Market Drivers
12.3 Heart Failure Drugs Market Challenges
12.4 Heart Failure Drugs Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Heart Failure Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Heart Failure Drugs Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 ACEI
1.2.3 Angiotensin II Receptor Blockers
1.2.4 ARNIs
1.2.5 Beta Blockers
1.2.6 Aldosterone Antagonists
1.2.7 Diuretics
1.3 Market by Application
1.3.1 Global Heart Failure Drugs Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Reduced Ejection Fraction
1.3.3 Preserved Ejection Fraction
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Heart Failure Drugs Market Size Estimates and Forecasts
2.1.1 Global Heart Failure Drugs Revenue 2020-2031
2.1.2 Global Heart Failure Drugs Sales 2020-2031
2.2 Heart Failure Drugs Market Size by Region: 2024 Versus 2031
2.3 Heart Failure Drugs Sales by Region (2020-2031)
2.3.1 Global Heart Failure Drugs Sales by Region: 2020-2025
2.3.2 Global Heart Failure Drugs Sales Forecast by Region (2026-2031)
2.3.3 Global Heart Failure Drugs Sales Market Share by Region (2020-2031)
2.4 Heart Failure Drugs Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Heart Failure Drugs Revenue by Region: 2020-2025
2.4.2 Global Heart Failure Drugs Revenue Forecast by Region (2026-2031)
2.4.3 Global Heart Failure Drugs Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Heart Failure Drugs Sales by Type (2020-2031)
3.1.1.1 Global Heart Failure Drugs Sales Volume by Type (2020-2031)
3.1.1.2 Global Heart Failure Drugs Sales Market Share by Type (2020-2031)
3.1.2 Global Heart Failure Drugs Revenue by Type (2020-2031)
3.1.2.1 Global Heart Failure Drugs Revenue by Type (2020-2031)
3.1.2.2 Global Heart Failure Drugs Revenue Market Share by Type (2020-2031)
3.1.3 Heart Failure Drugs Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Heart Failure Drugs Sales by Application (2020-2031)
3.2.1.1 Global Heart Failure Drugs Sales Volume by Application (2020-2031)
3.2.1.2 Global Heart Failure Drugs Sales Market Share by Application (2020-2031)
3.2.2 Global Heart Failure Drugs Revenue by Application (2020-2031)
3.2.2.1 Global Heart Failure Drugs Revenue by Application (2020-2031)
3.2.2.2 Global Heart Failure Drugs Revenue Market Share by Application (2020-2031)
3.2.3 Heart Failure Drugs Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 ACEI of Heart Failure Drugs Revenue Market Share by Application
3.3.2 Angiotensin II Receptor Blockers of Heart Failure Drugs Revenue Market Share by Application
3.3.3 ARNIs of Heart Failure Drugs Revenue Market Share by Application
3.3.4 Beta Blockers of Heart Failure Drugs Revenue Market Share by Application
3.3.5 Aldosterone Antagonists of Heart Failure Drugs Revenue Market Share by Application
3.3.6 Diuretics of Heart Failure Drugs Revenue Market Share by Application
4 Global Heart Failure Drugs by Manufacturers
4.1 Global Top Heart Failure Drugs Manufacturers by Sales (2020-2025)
4.1.1 Global Heart Failure Drugs Sales by Manufacturer (2020-2025)
4.1.2 Global Heart Failure Drugs Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Heart Failure Drugs Manufacturers by Revenue (2020-2025)
4.2.1 Global Heart Failure Drugs Revenue by Manufacturer (2020-2025)
4.2.2 Global Heart Failure Drugs Revenue Share by Manufacturer (2020-2025)
4.3 Global Heart Failure Drugs Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Heart Failure Drugs Manufacturers Covered: Ranking by Revenue
4.4.2 Global Heart Failure Drugs Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Heart Failure Drugs Manufacturing Base Distribution, Product Type
4.5.1 Heart Failure Drugs Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Heart Failure Drugs Market
4.5.3 Manufacturers Heart Failure Drugs Product Type and Application
4.5.4 ACEI Market Sales of Heart Failure Drugs by Manufacturer
4.5.5 Angiotensin II Receptor Blockers Market Sales of Heart Failure Drugs by Manufacturer
4.5.6 ARNIs Market Sales of Heart Failure Drugs by Manufacturer
4.5.7 Beta Blockers Market Sales of Heart Failure Drugs by Manufacturer
4.5.8 Aldosterone Antagonists Market Sales of Heart Failure Drugs by Manufacturer
4.5.9 Diuretics Market Sales of Heart Failure Drugs by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Novartis
5.1.1 Novartis Company Information
5.1.2 Novartis Description, Business Overview
5.1.3 Novartis Heart Failure Drugs Products Offered
5.1.4 Novartis Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Novartis Heart Failure Drugs Sales by Product in 2024
5.1.6 Novartis Heart Failure Drugs Sales by Application in 2024
5.1.7 Novartis Heart Failure Drugs Sales by Geographic Area in 2024
5.1.8 Novartis Recent Developments
5.2 Pfizer
5.2.1 Pfizer Company Information
5.2.2 Pfizer Description, Business Overview
5.2.3 Pfizer Heart Failure Drugs Products Offered
5.2.4 Pfizer Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Pfizer Heart Failure Drugs Sales by Product in 2024
5.2.6 Pfizer Heart Failure Drugs Sales by Application in 2024
5.2.7 Pfizer Heart Failure Drugs Sales by Geographic Area in 2024
5.2.8 Pfizer Recent Developments
5.3 AstraZeneca
5.3.1 AstraZeneca Company Information
5.3.2 AstraZeneca Description, Business Overview
5.3.3 AstraZeneca Heart Failure Drugs Products Offered
5.3.4 AstraZeneca Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.3.5 AstraZeneca Heart Failure Drugs Sales by Product in 2024
5.3.6 AstraZeneca Heart Failure Drugs Sales by Application in 2024
5.3.7 AstraZeneca Heart Failure Drugs Sales by Geographic Area in 2024
5.3.8 AstraZeneca Recent Developments
5.4 Hikma
5.4.1 Hikma Company Information
5.4.2 Hikma Description, Business Overview
5.4.3 Hikma Heart Failure Drugs Products Offered
5.4.4 Hikma Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Hikma Heart Failure Drugs Sales by Product in 2024
5.4.6 Hikma Heart Failure Drugs Sales by Application in 2024
5.4.7 Hikma Heart Failure Drugs Sales by Geographic Area in 2024
5.4.8 Hikma Recent Developments
5.5 Teva
5.5.1 Teva Company Information
5.5.2 Teva Description, Business Overview
5.5.3 Teva Heart Failure Drugs Products Offered
5.5.4 Teva Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Teva Heart Failure Drugs Sales by Product in 2024
5.5.6 Teva Heart Failure Drugs Sales by Application in 2024
5.5.7 Teva Heart Failure Drugs Sales by Geographic Area in 2024
5.5.8 Teva Recent Developments
5.6 Cipla
5.6.1 Cipla Company Information
5.6.2 Cipla Description, Business Overview
5.6.3 Cipla Heart Failure Drugs Products Offered
5.6.4 Cipla Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Cipla Heart Failure Drugs Sales by Product in 2024
5.6.6 Cipla Heart Failure Drugs Sales by Application in 2024
5.6.7 Cipla Heart Failure Drugs Sales by Geographic Area in 2024
5.6.8 Cipla Recent Developments
5.7 Merck & Co.
5.7.1 Merck & Co. Company Information
5.7.2 Merck & Co. Description, Business Overview
5.7.3 Merck & Co. Heart Failure Drugs Products Offered
5.7.4 Merck & Co. Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Merck & Co. Heart Failure Drugs Sales by Product in 2024
5.7.6 Merck & Co. Heart Failure Drugs Sales by Application in 2024
5.7.7 Merck & Co. Heart Failure Drugs Sales by Geographic Area in 2024
5.7.8 Merck & Co. Recent Developments
5.8 Amgen
5.8.1 Amgen Company Information
5.8.2 Amgen Description, Business Overview
5.8.3 Amgen Heart Failure Drugs Products Offered
5.8.4 Amgen Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Amgen Heart Failure Drugs Sales by Product in 2024
5.8.6 Amgen Heart Failure Drugs Sales by Application in 2024
5.8.7 Amgen Heart Failure Drugs Sales by Geographic Area in 2024
5.8.8 Amgen Recent Developments
5.9 Roche
5.9.1 Roche Company Information
5.9.2 Roche Description, Business Overview
5.9.3 Roche Heart Failure Drugs Products Offered
5.9.4 Roche Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Roche Heart Failure Drugs Sales by Product in 2024
5.9.6 Roche Heart Failure Drugs Sales by Application in 2024
5.9.7 Roche Heart Failure Drugs Sales by Geographic Area in 2024
5.9.8 Roche Recent Developments
5.10 Sun Pharma
5.10.1 Sun Pharma Company Information
5.10.2 Sun Pharma Description, Business Overview
5.10.3 Sun Pharma Heart Failure Drugs Products Offered
5.10.4 Sun Pharma Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Sun Pharma Heart Failure Drugs Sales by Product in 2024
5.10.6 Sun Pharma Heart Failure Drugs Sales by Application in 2024
5.10.7 Sun Pharma Heart Failure Drugs Sales by Geographic Area in 2024
5.10.8 Sun Pharma Recent Developments
5.11 Mylan
5.11.1 Mylan Company Information
5.11.2 Mylan Description, Business Overview
5.11.3 Mylan Heart Failure Drugs Products Offered
5.11.4 Mylan Heart Failure Drugs Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Mylan Heart Failure Drugs Sales by Product in 2024
5.11.6 Mylan Heart Failure Drugs Sales by Application in 2024
5.11.7 Mylan Heart Failure Drugs Sales by Geographic Area in 2024
5.11.8 Mylan Recent Developments
6 North America
6.1 North America Heart Failure Drugs Market Size YoY Growth 2020-2031
6.2 North America Heart Failure Drugs Market Facts & Figures by Country
6.2.1 North America Heart Failure Drugs Sales by Country (2020-2031)
6.2.2 North America Heart Failure Drugs Revenue by Country (2020-2031)
6.3 North America Heart Failure Drugs Sales by Type (2020-2025)
6.4 North America Heart Failure Drugs Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Heart Failure Drugs Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Heart Failure Drugs Market Facts & Figures by Region
7.2.1 Asia-Pacific Heart Failure Drugs Sales by Region (2020-2031)
7.2.2 Asia-Pacific Heart Failure Drugs Revenue by Region (2020-2031)
7.3 Asia-Pacific Heart Failure Drugs Sales by Type (2020-2025)
7.4 Asia-Pacific Heart Failure Drugs Sales by Application (2020-2025)
8 Europe
8.1 Europe Heart Failure Drugs Market Size YoY Growth 2020-2031
8.2 Europe Heart Failure Drugs Market Facts & Figures by Country
8.2.1 Europe Heart Failure Drugs Sales by Country (2020-2031)
8.2.2 Europe Heart Failure Drugs Revenue by Country (2020-2031)
8.3 Europe Heart Failure Drugs Sales by Type (2020-2025)
8.4 Europe Heart Failure Drugs Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Heart Failure Drugs Market Size YoY Growth 2020-2031
9.2 Latin America Heart Failure Drugs Market Facts & Figures by Country
9.2.1 Latin America Heart Failure Drugs Sales by Country (2020-2031)
9.2.2 Latin America Heart Failure Drugs Revenue by Country (2020-2031)
9.3 Latin America Heart Failure Drugs Sales by Type (2020-2025)
9.4 Latin America Heart Failure Drugs Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Heart Failure Drugs Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Heart Failure Drugs Market Facts & Figures by Country
10.2.1 Middle East and Africa Heart Failure Drugs Sales by Country (2020-2031)
10.2.2 Middle East and Africa Heart Failure Drugs Revenue by Country (2020-2031)
10.3 Middle East and Africa Heart Failure Drugs Sales by Type (2020-2025)
10.4 Middle East and Africa Heart Failure Drugs Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Heart Failure Drugs Supply Chain Analysis
11.2 Heart Failure Drugs Key Raw Materials and Upstream Suppliers
11.3 Heart Failure Drugs Clients Analysis
11.4 Heart Failure Drugs Sales Channel and Sales Model Analysis
11.4.1 Heart Failure Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Heart Failure Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Heart Failure Drugs Distributors
12 Heart Failure Drugs Market Dynamics
12.1 Heart Failure Drugs Industry Trends
12.2 Heart Failure Drugs Market Drivers
12.3 Heart Failure Drugs Market Challenges
12.4 Heart Failure Drugs Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Heart Failure Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Heart Failure Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Heart Failure Drugs Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Heart Failure Drugs Sales by Region (2020-2025) & (MT)
Table 5. Global Heart Failure Drugs Sales Forecast by Region (2026-2031) & (MT)
Table 6. Global Heart Failure Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Heart Failure Drugs Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Heart Failure Drugs Sales Volume by Type (2020-2025) & (MT)
Table 9. Global Heart Failure Drugs Sales Volume by Type (2026-2031) & (MT)
Table 10. Global Heart Failure Drugs Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Heart Failure Drugs Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Heart Failure Drugs Sales Volume by Application (2020-2025) & (MT)
Table 13. Global Heart Failure Drugs Sales Volume by Application (2026-2031) & (MT)
Table 14. Global Heart Failure Drugs Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Heart Failure Drugs Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Heart Failure Drugs Sales by Manufacturer (2020-2025) & (MT)
Table 17. Global Heart Failure Drugs Sales Share by Manufacturer (2020-2025)
Table 18. Heart Failure Drugs Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Heart Failure Drugs Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Heart Failure Drugs Price (2020-2025) & (USD/MT)
Table 21. Ranking of Global Top Heart Failure Drugs Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Heart Failure Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Heart Failure Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heart Failure Drugs as of 2024)
Table 24. Heart Failure Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Heart Failure Drugs Market
Table 26. Manufacturers Heart Failure Drugs Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Novartis Company Information
Table 29. Novartis Description and Business Overview
Table 30. Novartis Heart Failure Drugs Product
Table 31. Novartis Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 32. Novartis Sales Proportion of Heart Failure Drugs by Product in 2024
Table 33. Novartis Sales Proportion of Heart Failure Drugs by Application in 2024
Table 34. Novartis Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 35. Novartis Recent Developments
Table 36. Pfizer Company Information
Table 37. Pfizer Description and Business Overview
Table 38. Pfizer Heart Failure Drugs Product
Table 39. Pfizer Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 40. Pfizer Sales Proportion of Heart Failure Drugs by Product in 2024
Table 41. Pfizer Sales Proportion of Heart Failure Drugs by Application in 2024
Table 42. Pfizer Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 43. Pfizer Recent Developments
Table 44. AstraZeneca Company Information
Table 45. AstraZeneca Description and Business Overview
Table 46. AstraZeneca Heart Failure Drugs Product
Table 47. AstraZeneca Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 48. AstraZeneca Sales Proportion of Heart Failure Drugs by Product in 2024
Table 49. AstraZeneca Sales Proportion of Heart Failure Drugs by Application in 2024
Table 50. AstraZeneca Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 51. AstraZeneca Recent Developments
Table 52. Hikma Company Information
Table 53. Hikma Description and Business Overview
Table 54. Hikma Heart Failure Drugs Product
Table 55. Hikma Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. Hikma Sales Proportion of Heart Failure Drugs by Product in 2024
Table 57. Hikma Sales Proportion of Heart Failure Drugs by Application in 2024
Table 58. Hikma Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 59. Hikma Recent Developments
Table 60. Teva Company Information
Table 61. Teva Description and Business Overview
Table 62. Teva Heart Failure Drugs Product
Table 63. Teva Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 64. Teva Sales Proportion of Heart Failure Drugs by Product in 2024
Table 65. Teva Sales Proportion of Heart Failure Drugs by Application in 2024
Table 66. Teva Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 67. Teva Recent Developments
Table 68. Cipla Company Information
Table 69. Cipla Description and Business Overview
Table 70. Cipla Heart Failure Drugs Product
Table 71. Cipla Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 72. Cipla Sales Proportion of Heart Failure Drugs by Product in 2024
Table 73. Cipla Sales Proportion of Heart Failure Drugs by Application in 2024
Table 74. Cipla Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 75. Cipla Recent Developments
Table 76. Merck & Co. Company Information
Table 77. Merck & Co. Description and Business Overview
Table 78. Merck & Co. Heart Failure Drugs Product
Table 79. Merck & Co. Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Merck & Co. Sales Proportion of Heart Failure Drugs by Product in 2024
Table 81. Merck & Co. Sales Proportion of Heart Failure Drugs by Application in 2024
Table 82. Merck & Co. Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 83. Merck & Co. Recent Developments
Table 84. Amgen Company Information
Table 85. Amgen Description and Business Overview
Table 86. Amgen Heart Failure Drugs Product
Table 87. Amgen Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Amgen Sales Proportion of Heart Failure Drugs by Product in 2024
Table 89. Amgen Sales Proportion of Heart Failure Drugs by Application in 2024
Table 90. Amgen Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 91. Amgen Recent Developments
Table 92. Roche Company Information
Table 93. Roche Description and Business Overview
Table 94. Roche Heart Failure Drugs Product
Table 95. Roche Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Roche Sales Proportion of Heart Failure Drugs by Product in 2024
Table 97. Roche Sales Proportion of Heart Failure Drugs by Application in 2024
Table 98. Roche Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 99. Roche Recent Developments
Table 100. Sun Pharma Company Information
Table 101. Sun Pharma Description and Business Overview
Table 102. Sun Pharma Heart Failure Drugs Product
Table 103. Sun Pharma Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Sun Pharma Sales Proportion of Heart Failure Drugs by Product in 2024
Table 105. Sun Pharma Sales Proportion of Heart Failure Drugs by Application in 2024
Table 106. Sun Pharma Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 107. Sun Pharma Recent Developments
Table 108. Mylan Company Information
Table 109. Mylan Description and Business Overview
Table 110. Mylan Heart Failure Drugs Product
Table 111. Mylan Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Mylan Sales Proportion of Heart Failure Drugs by Product in 2024
Table 113. Mylan Sales Proportion of Heart Failure Drugs by Application in 2024
Table 114. Mylan Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 115. Mylan Recent Developments
Table 116. North America Heart Failure Drugs Sales by Country (2020-2025) & (MT)
Table 117. North America Heart Failure Drugs Sales by Country (2026-2031) & (MT)
Table 118. North America Heart Failure Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 119. North America Heart Failure Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 120. North America Heart Failure Drugs Sales by Type (2020-2025) & (MT)
Table 121. North America Heart Failure Drugs Sales by Application (2020-2025) & (MT)
Table 122. Asia-Pacific Heart Failure Drugs Sales by Region (2020-2025) & (MT)
Table 123. Asia-Pacific Heart Failure Drugs Sales by Region (2026-2031) & (MT)
Table 124. Asia-Pacific Heart Failure Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 125. Asia-Pacific Heart Failure Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 126. Asia-Pacific Heart Failure Drugs Sales by Type (2020-2025) & (MT)
Table 127. Asia-Pacific Heart Failure Drugs Sales by Application (2020-2025) & (MT)
Table 128. Europe Heart Failure Drugs Sales by Country (2020-2025) & (MT)
Table 129. Europe Heart Failure Drugs Sales by Country (2026-2031) & (MT)
Table 130. Europe Heart Failure Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 131. Europe Heart Failure Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 132. Europe Heart Failure Drugs Sales by Type (2020-2025) & (MT)
Table 133. Europe Heart Failure Drugs Sales by Application (2020-2025) & (MT)
Table 134. Latin America Heart Failure Drugs Sales by Country (2020-2025) & (MT)
Table 135. Latin America Heart Failure Drugs Sales by Country (2026-2031) & (MT)
Table 136. Latin America Heart Failure Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 137. Latin America Heart Failure Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 138. Latin America Heart Failure Drugs Sales by Type (2020-2025) & (MT)
Table 139. Latin America Heart Failure Drugs Sales by Application (2020-2025) & (MT)
Table 140. Middle East and Africa Heart Failure Drugs Sales by Country (2020-2025) & (MT)
Table 141. Middle East and Africa Heart Failure Drugs Sales by Country (2026-2031) & (MT)
Table 142. Middle East and Africa Heart Failure Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 143. Middle East and Africa Heart Failure Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 144. Middle East and Africa Heart Failure Drugs Sales by Type (2020-2025) & (MT)
Table 145. Middle East and Africa Heart Failure Drugs Sales by Application (2020-2025) & (MT)
Table 146. Heart Failure Drugs Key Raw Materials, Industry Status and Trend
Table 147. Heart Failure Drugs Key Raw Materials and Upstream Suppliers
Table 148. Heart Failure Drugs Clients Status and Trend
Table 149. Heart Failure Drugs Typical Clients
Table 150. Heart Failure Drugs Distributors
Table 151. Heart Failure Drugs Market Trends
Table 152. Heart Failure Drugs Market Drivers
Table 153. Heart Failure Drugs Market Challenges
Table 154. Heart Failure Drugs Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 158. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Heart Failure Drugs Product Picture
Figure 2. Global Heart Failure Drugs Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Heart Failure Drugs Sales Market Share by Type in 2024 & 2031
Figure 4. ACEI Product Picture
Figure 5. Angiotensin II Receptor Blockers Product Picture
Figure 6. ARNIs Product Picture
Figure 7. Beta Blockers Product Picture
Figure 8. Aldosterone Antagonists Product Picture
Figure 9. Diuretics Product Picture
Figure 10. Global Heart Failure Drugs Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 11. Global Heart Failure Drugs Sales Market Share by Application in 2024 & 2031
Figure 12. Reduced Ejection Fraction
Figure 13. Preserved Ejection Fraction
Figure 14. Heart Failure Drugs Report Years Considered
Figure 15. Global Heart Failure Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Heart Failure Drugs Market Size 2020-2031 (US$ Million)
Figure 17. Global Heart Failure Drugs Sales 2020-2031 (MT)
Figure 18. Global Heart Failure Drugs Sales Market Share Forecast by Region (2020-2031)
Figure 19. Global Heart Failure Drugs Revenue Market Share by Region (2020-2031)
Figure 20. Global Heart Failure Drugs Sales Market Share Forecast by Type (2020-2031)
Figure 21. Global Heart Failure Drugs Revenue Market Share Forecast by Type (2020-2031)
Figure 22. Heart Failure Drugs Average Selling Price (ASP) by Type (2020-2025) & (USD/MT)
Figure 23. Global Heart Failure Drugs Sales Market Share Forecast by Application (2020-2031)
Figure 24. Global Heart Failure Drugs Revenue Market Share Forecast by Application (2020-2031)
Figure 25. Heart Failure Drugs Average Selling Price (ASP) by Application (2020-2025) & (USD/MT)
Figure 26. ACEI of Heart Failure Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 27. Angiotensin II Receptor Blockers of Heart Failure Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 28. ARNIs of Heart Failure Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 29. Beta Blockers of Heart Failure Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 30. Aldosterone Antagonists of Heart Failure Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 31. Diuretics of Heart Failure Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 32. Global Heart Failure Drugs Sales Share by Manufacturer in 2024
Figure 33. Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 34. ACEI Market Sales Proportion by Manufacturer in 2024
Figure 35. Angiotensin II Receptor Blockers Market Sales Proportion by Manufacturer in 2024
Figure 36. ARNIs Market Sales Proportion by Manufacturer in 2024
Figure 37. Beta Blockers Market Sales Proportion by Manufacturer in 2024
Figure 38. Aldosterone Antagonists Market Sales Proportion by Manufacturer in 2024
Figure 39. Diuretics Market Sales Proportion by Manufacturer in 2024
Figure 40. North America Heart Failure Drugs Revenue 2020-2031 (US$ Million)
Figure 41. North America Heart Failure Drugs Sales Market Share by Type (2020-2025)
Figure 42. North America Heart Failure Drugs Sales Market Share by Application (2020-2025)
Figure 43. Asia-Pacific Heart Failure Drugs Revenue 2020-2031 (US$ Million)
Figure 44. Asia-Pacific Heart Failure Drugs Sales Market Share by Region (2020-2031)
Figure 45. Asia-Pacific Heart Failure Drugs Revenue Market Share by Region (2020-2031)
Figure 46. Asia-Pacific Heart Failure Drugs Sales Market Share by Type (2020-2025)
Figure 47. Asia-Pacific Heart Failure Drugs Sales Market Share by Application (2020-2025)
Figure 48. Europe Heart Failure Drugs Revenue Growth Rate 2020-2031 (US$ Million)
Figure 49. Europe Heart Failure Drugs Sales Market Share by Country (2020-2031)
Figure 50. Europe Heart Failure Drugs Revenue Market Share by Country (2020-2031)
Figure 51. Europe Heart Failure Drugs Sales Market Share by Type (2020-2025)
Figure 52. Europe Heart Failure Drugs Sales Market Share by Application (2020-2025)
Figure 53. Latin America Heart Failure Drugs Revenue Growth Rate 2020-2031 (US$ Million)
Figure 54. Latin America Heart Failure Drugs Sales Market Share by Country (2020-2031)
Figure 55. Latin America Heart Failure Drugs Revenue Market Share by Country (2020-2025)
Figure 56. Latin America Heart Failure Drugs Sales Market Share by Type (2020-2025)
Figure 57. Latin America Heart Failure Drugs Sales Market Share by Application (2020-2025)
Figure 58. Middle East and Africa Heart Failure Drugs Revenue Growth Rate 2020-2031 (US$ Million)
Figure 59. Middle East and Africa Heart Failure Drugs Sales Market Share by Country (2020-2031)
Figure 60. Middle East and Africa Heart Failure Drugs Revenue Market Share by Country (2020-2031)
Figure 61. Middle East and Africa Heart Failure Drugs Sales Market Share by Type (2020-2025)
Figure 62. Middle East and Africa Heart Failure Drugs Sales Market Share by Application (2020-2025)
Figure 63. Heart Failure Drugs Supply Chain (Upstream and Downstream Market)
Figure 64. Global Production Market Share of Heart Failure Drugs Raw Materials by Region in 2024
Figure 65. Heart Failure Drugs Distribution Channels
Figure 66. Global Heart Failure Drugs Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 67. Global Heart Failure Drugs Percentage 2020-2031: Online Sales VS Offline Sales
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Heart Failure Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Heart Failure Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Heart Failure Drugs Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Heart Failure Drugs Sales by Region (2020-2025) & (MT)
Table 5. Global Heart Failure Drugs Sales Forecast by Region (2026-2031) & (MT)
Table 6. Global Heart Failure Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Heart Failure Drugs Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Heart Failure Drugs Sales Volume by Type (2020-2025) & (MT)
Table 9. Global Heart Failure Drugs Sales Volume by Type (2026-2031) & (MT)
Table 10. Global Heart Failure Drugs Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Heart Failure Drugs Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Heart Failure Drugs Sales Volume by Application (2020-2025) & (MT)
Table 13. Global Heart Failure Drugs Sales Volume by Application (2026-2031) & (MT)
Table 14. Global Heart Failure Drugs Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Heart Failure Drugs Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Heart Failure Drugs Sales by Manufacturer (2020-2025) & (MT)
Table 17. Global Heart Failure Drugs Sales Share by Manufacturer (2020-2025)
Table 18. Heart Failure Drugs Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Heart Failure Drugs Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Heart Failure Drugs Price (2020-2025) & (USD/MT)
Table 21. Ranking of Global Top Heart Failure Drugs Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Heart Failure Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Heart Failure Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heart Failure Drugs as of 2024)
Table 24. Heart Failure Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Heart Failure Drugs Market
Table 26. Manufacturers Heart Failure Drugs Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Novartis Company Information
Table 29. Novartis Description and Business Overview
Table 30. Novartis Heart Failure Drugs Product
Table 31. Novartis Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 32. Novartis Sales Proportion of Heart Failure Drugs by Product in 2024
Table 33. Novartis Sales Proportion of Heart Failure Drugs by Application in 2024
Table 34. Novartis Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 35. Novartis Recent Developments
Table 36. Pfizer Company Information
Table 37. Pfizer Description and Business Overview
Table 38. Pfizer Heart Failure Drugs Product
Table 39. Pfizer Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 40. Pfizer Sales Proportion of Heart Failure Drugs by Product in 2024
Table 41. Pfizer Sales Proportion of Heart Failure Drugs by Application in 2024
Table 42. Pfizer Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 43. Pfizer Recent Developments
Table 44. AstraZeneca Company Information
Table 45. AstraZeneca Description and Business Overview
Table 46. AstraZeneca Heart Failure Drugs Product
Table 47. AstraZeneca Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 48. AstraZeneca Sales Proportion of Heart Failure Drugs by Product in 2024
Table 49. AstraZeneca Sales Proportion of Heart Failure Drugs by Application in 2024
Table 50. AstraZeneca Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 51. AstraZeneca Recent Developments
Table 52. Hikma Company Information
Table 53. Hikma Description and Business Overview
Table 54. Hikma Heart Failure Drugs Product
Table 55. Hikma Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. Hikma Sales Proportion of Heart Failure Drugs by Product in 2024
Table 57. Hikma Sales Proportion of Heart Failure Drugs by Application in 2024
Table 58. Hikma Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 59. Hikma Recent Developments
Table 60. Teva Company Information
Table 61. Teva Description and Business Overview
Table 62. Teva Heart Failure Drugs Product
Table 63. Teva Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 64. Teva Sales Proportion of Heart Failure Drugs by Product in 2024
Table 65. Teva Sales Proportion of Heart Failure Drugs by Application in 2024
Table 66. Teva Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 67. Teva Recent Developments
Table 68. Cipla Company Information
Table 69. Cipla Description and Business Overview
Table 70. Cipla Heart Failure Drugs Product
Table 71. Cipla Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 72. Cipla Sales Proportion of Heart Failure Drugs by Product in 2024
Table 73. Cipla Sales Proportion of Heart Failure Drugs by Application in 2024
Table 74. Cipla Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 75. Cipla Recent Developments
Table 76. Merck & Co. Company Information
Table 77. Merck & Co. Description and Business Overview
Table 78. Merck & Co. Heart Failure Drugs Product
Table 79. Merck & Co. Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Merck & Co. Sales Proportion of Heart Failure Drugs by Product in 2024
Table 81. Merck & Co. Sales Proportion of Heart Failure Drugs by Application in 2024
Table 82. Merck & Co. Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 83. Merck & Co. Recent Developments
Table 84. Amgen Company Information
Table 85. Amgen Description and Business Overview
Table 86. Amgen Heart Failure Drugs Product
Table 87. Amgen Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Amgen Sales Proportion of Heart Failure Drugs by Product in 2024
Table 89. Amgen Sales Proportion of Heart Failure Drugs by Application in 2024
Table 90. Amgen Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 91. Amgen Recent Developments
Table 92. Roche Company Information
Table 93. Roche Description and Business Overview
Table 94. Roche Heart Failure Drugs Product
Table 95. Roche Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Roche Sales Proportion of Heart Failure Drugs by Product in 2024
Table 97. Roche Sales Proportion of Heart Failure Drugs by Application in 2024
Table 98. Roche Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 99. Roche Recent Developments
Table 100. Sun Pharma Company Information
Table 101. Sun Pharma Description and Business Overview
Table 102. Sun Pharma Heart Failure Drugs Product
Table 103. Sun Pharma Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Sun Pharma Sales Proportion of Heart Failure Drugs by Product in 2024
Table 105. Sun Pharma Sales Proportion of Heart Failure Drugs by Application in 2024
Table 106. Sun Pharma Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 107. Sun Pharma Recent Developments
Table 108. Mylan Company Information
Table 109. Mylan Description and Business Overview
Table 110. Mylan Heart Failure Drugs Product
Table 111. Mylan Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Mylan Sales Proportion of Heart Failure Drugs by Product in 2024
Table 113. Mylan Sales Proportion of Heart Failure Drugs by Application in 2024
Table 114. Mylan Sales Proportion of Heart Failure Drugs by Geographic Area in 2024
Table 115. Mylan Recent Developments
Table 116. North America Heart Failure Drugs Sales by Country (2020-2025) & (MT)
Table 117. North America Heart Failure Drugs Sales by Country (2026-2031) & (MT)
Table 118. North America Heart Failure Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 119. North America Heart Failure Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 120. North America Heart Failure Drugs Sales by Type (2020-2025) & (MT)
Table 121. North America Heart Failure Drugs Sales by Application (2020-2025) & (MT)
Table 122. Asia-Pacific Heart Failure Drugs Sales by Region (2020-2025) & (MT)
Table 123. Asia-Pacific Heart Failure Drugs Sales by Region (2026-2031) & (MT)
Table 124. Asia-Pacific Heart Failure Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 125. Asia-Pacific Heart Failure Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 126. Asia-Pacific Heart Failure Drugs Sales by Type (2020-2025) & (MT)
Table 127. Asia-Pacific Heart Failure Drugs Sales by Application (2020-2025) & (MT)
Table 128. Europe Heart Failure Drugs Sales by Country (2020-2025) & (MT)
Table 129. Europe Heart Failure Drugs Sales by Country (2026-2031) & (MT)
Table 130. Europe Heart Failure Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 131. Europe Heart Failure Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 132. Europe Heart Failure Drugs Sales by Type (2020-2025) & (MT)
Table 133. Europe Heart Failure Drugs Sales by Application (2020-2025) & (MT)
Table 134. Latin America Heart Failure Drugs Sales by Country (2020-2025) & (MT)
Table 135. Latin America Heart Failure Drugs Sales by Country (2026-2031) & (MT)
Table 136. Latin America Heart Failure Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 137. Latin America Heart Failure Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 138. Latin America Heart Failure Drugs Sales by Type (2020-2025) & (MT)
Table 139. Latin America Heart Failure Drugs Sales by Application (2020-2025) & (MT)
Table 140. Middle East and Africa Heart Failure Drugs Sales by Country (2020-2025) & (MT)
Table 141. Middle East and Africa Heart Failure Drugs Sales by Country (2026-2031) & (MT)
Table 142. Middle East and Africa Heart Failure Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 143. Middle East and Africa Heart Failure Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 144. Middle East and Africa Heart Failure Drugs Sales by Type (2020-2025) & (MT)
Table 145. Middle East and Africa Heart Failure Drugs Sales by Application (2020-2025) & (MT)
Table 146. Heart Failure Drugs Key Raw Materials, Industry Status and Trend
Table 147. Heart Failure Drugs Key Raw Materials and Upstream Suppliers
Table 148. Heart Failure Drugs Clients Status and Trend
Table 149. Heart Failure Drugs Typical Clients
Table 150. Heart Failure Drugs Distributors
Table 151. Heart Failure Drugs Market Trends
Table 152. Heart Failure Drugs Market Drivers
Table 153. Heart Failure Drugs Market Challenges
Table 154. Heart Failure Drugs Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 158. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Heart Failure Drugs Product Picture
Figure 2. Global Heart Failure Drugs Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Heart Failure Drugs Sales Market Share by Type in 2024 & 2031
Figure 4. ACEI Product Picture
Figure 5. Angiotensin II Receptor Blockers Product Picture
Figure 6. ARNIs Product Picture
Figure 7. Beta Blockers Product Picture
Figure 8. Aldosterone Antagonists Product Picture
Figure 9. Diuretics Product Picture
Figure 10. Global Heart Failure Drugs Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 11. Global Heart Failure Drugs Sales Market Share by Application in 2024 & 2031
Figure 12. Reduced Ejection Fraction
Figure 13. Preserved Ejection Fraction
Figure 14. Heart Failure Drugs Report Years Considered
Figure 15. Global Heart Failure Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Heart Failure Drugs Market Size 2020-2031 (US$ Million)
Figure 17. Global Heart Failure Drugs Sales 2020-2031 (MT)
Figure 18. Global Heart Failure Drugs Sales Market Share Forecast by Region (2020-2031)
Figure 19. Global Heart Failure Drugs Revenue Market Share by Region (2020-2031)
Figure 20. Global Heart Failure Drugs Sales Market Share Forecast by Type (2020-2031)
Figure 21. Global Heart Failure Drugs Revenue Market Share Forecast by Type (2020-2031)
Figure 22. Heart Failure Drugs Average Selling Price (ASP) by Type (2020-2025) & (USD/MT)
Figure 23. Global Heart Failure Drugs Sales Market Share Forecast by Application (2020-2031)
Figure 24. Global Heart Failure Drugs Revenue Market Share Forecast by Application (2020-2031)
Figure 25. Heart Failure Drugs Average Selling Price (ASP) by Application (2020-2025) & (USD/MT)
Figure 26. ACEI of Heart Failure Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 27. Angiotensin II Receptor Blockers of Heart Failure Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 28. ARNIs of Heart Failure Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 29. Beta Blockers of Heart Failure Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 30. Aldosterone Antagonists of Heart Failure Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 31. Diuretics of Heart Failure Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 32. Global Heart Failure Drugs Sales Share by Manufacturer in 2024
Figure 33. Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 34. ACEI Market Sales Proportion by Manufacturer in 2024
Figure 35. Angiotensin II Receptor Blockers Market Sales Proportion by Manufacturer in 2024
Figure 36. ARNIs Market Sales Proportion by Manufacturer in 2024
Figure 37. Beta Blockers Market Sales Proportion by Manufacturer in 2024
Figure 38. Aldosterone Antagonists Market Sales Proportion by Manufacturer in 2024
Figure 39. Diuretics Market Sales Proportion by Manufacturer in 2024
Figure 40. North America Heart Failure Drugs Revenue 2020-2031 (US$ Million)
Figure 41. North America Heart Failure Drugs Sales Market Share by Type (2020-2025)
Figure 42. North America Heart Failure Drugs Sales Market Share by Application (2020-2025)
Figure 43. Asia-Pacific Heart Failure Drugs Revenue 2020-2031 (US$ Million)
Figure 44. Asia-Pacific Heart Failure Drugs Sales Market Share by Region (2020-2031)
Figure 45. Asia-Pacific Heart Failure Drugs Revenue Market Share by Region (2020-2031)
Figure 46. Asia-Pacific Heart Failure Drugs Sales Market Share by Type (2020-2025)
Figure 47. Asia-Pacific Heart Failure Drugs Sales Market Share by Application (2020-2025)
Figure 48. Europe Heart Failure Drugs Revenue Growth Rate 2020-2031 (US$ Million)
Figure 49. Europe Heart Failure Drugs Sales Market Share by Country (2020-2031)
Figure 50. Europe Heart Failure Drugs Revenue Market Share by Country (2020-2031)
Figure 51. Europe Heart Failure Drugs Sales Market Share by Type (2020-2025)
Figure 52. Europe Heart Failure Drugs Sales Market Share by Application (2020-2025)
Figure 53. Latin America Heart Failure Drugs Revenue Growth Rate 2020-2031 (US$ Million)
Figure 54. Latin America Heart Failure Drugs Sales Market Share by Country (2020-2031)
Figure 55. Latin America Heart Failure Drugs Revenue Market Share by Country (2020-2025)
Figure 56. Latin America Heart Failure Drugs Sales Market Share by Type (2020-2025)
Figure 57. Latin America Heart Failure Drugs Sales Market Share by Application (2020-2025)
Figure 58. Middle East and Africa Heart Failure Drugs Revenue Growth Rate 2020-2031 (US$ Million)
Figure 59. Middle East and Africa Heart Failure Drugs Sales Market Share by Country (2020-2031)
Figure 60. Middle East and Africa Heart Failure Drugs Revenue Market Share by Country (2020-2031)
Figure 61. Middle East and Africa Heart Failure Drugs Sales Market Share by Type (2020-2025)
Figure 62. Middle East and Africa Heart Failure Drugs Sales Market Share by Application (2020-2025)
Figure 63. Heart Failure Drugs Supply Chain (Upstream and Downstream Market)
Figure 64. Global Production Market Share of Heart Failure Drugs Raw Materials by Region in 2024
Figure 65. Heart Failure Drugs Distribution Channels
Figure 66. Global Heart Failure Drugs Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 67. Global Heart Failure Drugs Percentage 2020-2031: Online Sales VS Offline Sales
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232